Laboratory of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
Department of Thoracic Surgery II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, People's Republic of China
J Immunother Cancer. 2022 Oct;10(10). doi: 10.1136/jitc-2022-004868.
Although adoptive cell therapy with tumor infiltrating lymphocytes (TILs) has mediated effective antitumor responses in several cancers, dysfunction and exhaustion of TILs significantly impair the therapeutic effect of TILs. Thus, it is essential to elucidate the exhausted characteristics of TILs and improve the antitumor effect of TILs by reversing their exhaustion. Here, we focused on the influence of autophagy on TILs in terms of T-cell activation, proliferation, and differentiation in vitro and in vivo.
We first evaluated autophagy level of TILs and influence of spermidine treatment on autophagy levels of TILs. Furthermore, we assessed the proliferative potential, phenotypical characteristics, T cell receptor (TCR) repertoire and antitumor activity of TILs with and without spermidine treatment.
We found that autophagic flux of TILs, especially exhausted TILs that express inhibitory immunoreceptors and have impaired proliferative capacity and decreased production of cytotoxic effector molecules, was significantly impaired. The restoration of autophagic flux via spermidine treatment resulted in increased diversity of the TCR repertoire, reduced expression of inhibitory immunoreceptors (PD1, TIM3, or LAG3), enhanced proliferation and effector functions, which subsequently demonstrated the superior in vitro and in vivo antitumor activity of TILs. Our findings unveil that spermidine, as an autophagy inducer, reverses dysfunction and exhaustion of TILs and subsequently improves the antitumor activity of TILs.
These data suggest that spermidine treatment presents an opportunity to improve adoptive TIL therapy for the treatment of solid tumors.
虽然过继细胞疗法(adoptive cell therapy)利用肿瘤浸润淋巴细胞(tumor infiltrating lymphocytes,TILs)在几种癌症中已经介导了有效的抗肿瘤反应,但 TILs 的功能障碍和衰竭显著损害了 TILs 的治疗效果。因此,阐明 TILs 的衰竭特征,并通过逆转其衰竭来提高 TILs 的抗肿瘤效果至关重要。在这里,我们专注于自噬对 TILs 在体外和体内 T 细胞激活、增殖和分化方面的影响。
我们首先评估了 TILs 的自噬水平以及 spermidine 处理对 TILs 自噬水平的影响。此外,我们评估了经过 spermidine 处理和未经 spermidine 处理的 TILs 的增殖潜力、表型特征、T 细胞受体(TCR)库和抗肿瘤活性。
我们发现 TILs 的自噬通量,特别是表达抑制性免疫受体且增殖能力受损、细胞毒性效应分子产生减少的衰竭 TILs 的自噬通量明显受损。通过 spermidine 处理恢复自噬通量会导致 TCR 库的多样性增加,抑制性免疫受体(PD1、TIM3 或 LAG3)的表达减少,增殖和效应功能增强,从而证明 TILs 的体外和体内抗肿瘤活性更高。我们的研究结果揭示了 spermidine 作为一种自噬诱导剂,可以逆转 TILs 的功能障碍和衰竭,从而提高 TILs 的抗肿瘤活性。
这些数据表明,spermidine 处理为改善过继性 TIL 疗法治疗实体瘤提供了机会。